NCT00016328View on ClinicalTrials.gov

CCI-779 in Treating Patients With Recurrent Glioblastoma Multiforme

PHASE2CompletedINTERVENTIONAL
Enrollment

33

Participants

Timeline

Start Date

May 31, 2001

Primary Completion Date

August 31, 2005

Conditions
Adult Giant Cell GlioblastomaAdult GlioblastomaAdult GliosarcomaRecurrent Adult Brain Tumor
Interventions
DRUG

temsirolimus

Given IV

OTHER

laboratory biomarker analysis

Correlative studies

OTHER

pharmacological study

Correlative studies

Trial Locations (1)

55905

North Central Cancer Treatment Group, Rochester

All Listed Sponsors
lead

National Cancer Institute (NCI)

NIH

NCT00016328 - CCI-779 in Treating Patients With Recurrent Glioblastoma Multiforme | Biotech Hunter | Biotech Hunter